Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezio Zanon

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Hematology Reports|August 27, 2025
Advantages of FVIII-Extended Half-Life (Turoctocog Alfa Pegol) in the Management of Cardiac Surgery in a Patient with Mild Hemophilia A: A Case Report and Literature ReviewAngela Napolitano, Andrea Venturini, Mauro Ronzoni, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2020
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case reportEzio Zanon, Samantha Pasca, Elena Campello, et al.
Thrombosis and Haemostasis|February 13, 2004
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolismEzio Zanon, Graziella Saggiorato, Roberto Ramon, et al.
Thrombosis Research|July 20, 2020
Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®)Ezio Zanon, Samantha Pasca, Luca Spiezia, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Confirmation of the value of a modified long-distance polymerase chain reaction in the detection of inversion intron 22 in severe hemophilia a: a technical noteAnna Maria Lombardi, Laura Cabrio, Ezio Zanon, et al.
Angiology|April 5, 2008
Flow-mediated arterial dilation in primary antiphospholipid syndromeFranca Bilora, Maria Teresa Sartori, Ezio Zanon, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 17, 2010
Outcome of long-term prophylaxis after cerebral hemorrhage in a patient with severe hemophilia BEzio Zanon, Maria Teresa Sartori, Luca Spiezia, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2002
Are antiphospholipid antibodies an independent risk factor for atherosclerosis?Franca Bilora, Veronica Boccioletti, Bruno Girolami, et al.
Blood Transfusion = Trasfusione Del Sangue|June 10, 2015
Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in ItalyGiancarlo Castaman, Angiola Rocino, M Gabriella Mazzucconi, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2006
Does hemophilia protect against atherosclerosis? A case-control studyFranca Bilora, Ezio Zanon, Francesco Petrobelli, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Hematology Reports|August 27, 2025
Advantages of FVIII-Extended Half-Life (Turoctocog Alfa Pegol) in the Management of Cardiac Surgery in a Patient with Mild Hemophilia A: A Case Report and Literature ReviewAngela Napolitano, Andrea Venturini, Mauro Ronzoni, et al.
Journal of Thrombosis and Thrombolysis|July 18, 2020
How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case reportEzio Zanon, Samantha Pasca, Elena Campello, et al.
Thrombosis and Haemostasis|February 13, 2004
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolismEzio Zanon, Graziella Saggiorato, Roberto Ramon, et al.
Thrombosis Research|July 20, 2020
Acquired haemophilia A, concomitant acute myocardial infarction and urgent major surgery: How to successfully treat a critical patient with rpFVIII (Obizur®)Ezio Zanon, Samantha Pasca, Luca Spiezia, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 26, 2005
Confirmation of the value of a modified long-distance polymerase chain reaction in the detection of inversion intron 22 in severe hemophilia a: a technical noteAnna Maria Lombardi, Laura Cabrio, Ezio Zanon, et al.
Angiology|April 5, 2008
Flow-mediated arterial dilation in primary antiphospholipid syndromeFranca Bilora, Maria Teresa Sartori, Ezio Zanon, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 17, 2010
Outcome of long-term prophylaxis after cerebral hemorrhage in a patient with severe hemophilia BEzio Zanon, Maria Teresa Sartori, Luca Spiezia, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 18, 2002
Are antiphospholipid antibodies an independent risk factor for atherosclerosis?Franca Bilora, Veronica Boccioletti, Bruno Girolami, et al.
Blood Transfusion = Trasfusione Del Sangue|June 10, 2015
Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in ItalyGiancarlo Castaman, Angiola Rocino, M Gabriella Mazzucconi, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|May 19, 2006
Does hemophilia protect against atherosclerosis? A case-control studyFranca Bilora, Ezio Zanon, Francesco Petrobelli, et al.
Pageof 8